<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00110838</url>
  </required_header>
  <id_info>
    <org_study_id>TME/C-01.07</org_study_id>
    <nct_id>NCT00110838</nct_id>
  </id_info>
  <brief_title>SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia</brief_title>
  <official_title>Study on Omega-3 Fatty Acids and Ventricular Arrhythmia, a Parallel, Placebo-Controlled, Double Blind Intervention Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wageningen Centre for Food Sciences</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>SEAFOODplus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Wageningen Centre for Food Sciences</source>
  <brief_summary>
    <textblock>
      The objective of the SOFA trial is to investigate whether supplemental intake of n-3
      polyunsaturated fatty acids (n-3 PUFA) from fish oil can reduce the recurrence of
      life-threatening ventricular arrhythmias in patients with an implantable cardioverter
      defibrillator (ICD).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Previous human observational studies and clinical trials provide strong indications that n-3
      PUFA from fish can prevent cardiovascular disease. Striking is that these studies show a
      strong relation between n-3 PUFA and sudden death, but not between n-3 PUFA and non-fatal
      heart disease. Sudden death is one of the most common and often the first manifestation of
      coronary heart disease. The majority of sudden deaths are directly caused by acute
      ventricular arrhythmia. Our hypothesis is that n-3 PUFA prevents sudden death by suppressing
      life-threatening cardiac arrhythmia. Therefore, we investigate in a randomized controlled
      clinical trial whether supplemental intake of n-3 PUFA from fish can reduce the incidence of
      life-threatening cardiac arrhythmias. Our population consists of patients with an implantable
      cardioverter defibrillator (ICD), because this device records all arrhythmic events in a
      memory chip. As the ICD enables continuous monitoring of events in nonhospitalised patients,
      this population is very suitable for testing a possible antiarrhythmic effect of n-3 PUFA.
      The objective of the SOFA trial is to investigate the effect of fish oil on the incidence of
      recurrent ventricular arrhythmia in patients with an ICD. The SOFA is a randomised, parallel,
      placebo-controlled, double-blind intervention study which is currently being carried out in
      26 cardiology centers in Europe. Five hundred forty six patients with an ICD are randomised
      to receive either 2g/d of fish oil or placebo oil for a period up to 12 months. The primary
      outcome is spontaneous ventricular tachyarrhythmias as detected by the ICD or all-cause
      mortality within 12 months.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2001</start_date>
  <completion_date>January 2005</completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Occurrence of appropriate ICD intervention (shock or antitachycardia pacing) for spontaneous ventricular tachyarrhythmias, or all-cause mortality</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>All cause mortality (separately from ventricular tachyarrhythmia)</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac mortality</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All arrhythmic events as documented by the ICD Core laboratory</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in the prescription of antiarrhythmic drugs</measure>
  </secondary_outcome>
  <enrollment>546</enrollment>
  <condition>Arrhythmia</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Supplementation with fish oil versus placebo</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ICD is capable of recording ECG strips for at least 10 of its (attempted) therapeutic
             interventions

          -  18 years or older

          -  written informed consent

        Exclusion Criteria:

          -  Primary prophylactic indication

          -  ICD implantation as a ‘bridge’ to heart transplantation

          -  Refractory supraventricular arrhythmias with rapid ventricular rates despite
             antiarrhythmic therapy

          -  a projected lifespan of less than 1 year

          -  participation in another trial (during or within 30 days before SOFA)

          -  use of any supplemental n-3 fatty acid during the last 3 months

          -  intake of more than 8g of n-3 fatty acids from fish per month as judged by a fish
             frequency questionnaire

          -  pregnant women and women of childbearing potential who do not use adequate
             contraception

          -  patients known to have a history of recent drug or alcohol abuse
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Evert G Schouten, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Wageningen Centre for Food Sciences</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Wilhelminenspital</name>
      <address>
        <city>Vienna</city>
        <zip>A-1160</zip>
        <country>Austria</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Gent</name>
      <address>
        <city>Gent</city>
        <zip>B-9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Interni Kardiologicka Klinika</name>
      <address>
        <city>Brno</city>
        <zip>63900</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Institute of Clinical and Experimental Medicine</name>
      <address>
        <city>Prague</city>
        <zip>14021</zip>
        <country>Czech Republic</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Kerckhoff-Klinik GmbH</name>
      <address>
        <city>Bad Nauheim</city>
        <zip>D-61231</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Herz- und Diabeteszentrum Nordrhein-Westfalen</name>
      <address>
        <city>Bad Oeynhausen</city>
        <zip>D-32545</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum Benjamin Franklin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>12200</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Charité - Universitätsmedizin Berlin</name>
      <address>
        <city>Berlin</city>
        <zip>13353</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Klinikum der Friedrich-Schiller-Universitat</name>
      <address>
        <city>Jena</city>
        <zip>D-07747</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Universitatsklinikum Muenster</name>
      <address>
        <city>Muenster</city>
        <zip>48149</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Stiftsklinik Augustinum</name>
      <address>
        <city>Munich</city>
        <zip>81375</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Academic Medical Centre Amsterdam</name>
      <address>
        <city>Amsterdam</city>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Catharina Ziekenhuis</name>
      <address>
        <city>Eindhoven</city>
        <zip>5623 EJ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St. Antoniusziekenhuis</name>
      <address>
        <city>Nieuwegein</city>
        <zip>3435 CM</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Center Rotterdam Erasmus</name>
      <address>
        <city>Rotterdam</city>
        <zip>3015 GD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Medical Centre Utrecht</name>
      <address>
        <city>Utrecht</city>
        <zip>3584 CX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Wageningen Centre for Food Sciences</name>
      <address>
        <city>Wageningen</city>
        <zip>6703 HD</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Isala Klinieken (Locatie Wezenlanden)</name>
      <address>
        <city>Zwolle</city>
        <zip>8011 JW</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Medical University of Gdansk</name>
      <address>
        <city>Gdansk</city>
        <zip>80-211</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>I Klinika Kardiologii</name>
      <address>
        <city>Katowice</city>
        <zip>40-635</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Pomeranian Academy of Medicine</name>
      <address>
        <city>Szczecin</city>
        <zip>70-111</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Instytut Kardiologii</name>
      <address>
        <city>Warsaw</city>
        <zip>02-637</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Grochowski Hospital</name>
      <address>
        <city>Warsaw</city>
        <zip>04-073</zip>
        <country>Poland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire Voudois</name>
      <address>
        <city>Lausanne</city>
        <zip>1011</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital</name>
      <address>
        <city>Birmingham</city>
        <zip>B15 2TH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>St George Hospital Medical School</name>
      <address>
        <city>London</city>
        <zip>SW17 ORE</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Southampton General Hospital</name>
      <address>
        <city>Southampton</city>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Czech Republic</country>
    <country>Germany</country>
    <country>Netherlands</country>
    <country>Poland</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
  </location_countries>
  <link>
    <url>http://www.wcfs.nl</url>
    <description>Wageningen Centre for Food Sciences</description>
  </link>
  <reference>
    <citation>Brouwer IA, Zock PL, Wever EF, Hauer RN, Camm AJ, Böcker D, Otto-Terlouw P, Katan MB, Schouten EG. Rationale and design of a randomised controlled clinical trial on supplemental intake of n-3 fatty acids and incidence of cardiac arrhythmia: SOFA. Eur J Clin Nutr. 2003 Oct;57(10):1323-30.</citation>
    <PMID>14506496</PMID>
  </reference>
  <results_reference>
    <citation>Brouwer IA, Zock PL, Camm AJ, Böcker D, Hauer RN, Wever EF, Dullemeijer C, Ronden JE, Katan MB, Lubinski A, Buschler H, Schouten EG; SOFA Study Group. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006 Jun 14;295(22):2613-9.</citation>
    <PMID>16772624</PMID>
  </results_reference>
  <verification_date>May 2005</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 13, 2005</study_first_submitted>
  <study_first_submitted_qc>May 13, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 16, 2005</study_first_posted>
  <last_update_submitted>July 20, 2006</last_update_submitted>
  <last_update_submitted_qc>July 20, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2006</last_update_posted>
  <keyword>fish oil</keyword>
  <keyword>n-3 fatty acids</keyword>
  <keyword>n-3 PUFA</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>arrhythmia</keyword>
  <keyword>ICD</keyword>
  <keyword>human</keyword>
  <keyword>Patients with an implantable cardioverter defibrillator</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

